The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

Share Price Information for Directa Plus (DCTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.70
Bid: 18.40
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 0.60 (3.261%)
Open: 18.70
High: 18.70
Low: 18.70
Prev. Close: 18.70
DCTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

29 Sep 2022 07:00

RNS Number : 0614B
Directa Plus PLC
29 September 2022
 

29 September 2022

 

 

 

Directa Plus plc

("Directa Plus" or the "Company" or, together with its subsidiaries, the "Group")

 

Half Year Report for the Period Ended 30 June 2022

 

Strong Top Line Growth, Progress in All Key Vertical Markets

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene-based products for use in consumer and industrial markets, is pleased to announce its half year results for the six months ended 30 June 2022.

As previously announced in our recent pre-close trading update, during the period the Group delivered strong top line growth and maintained its focus on developing and delivering market leading products and services in its two core business verticals - Environmental Remediation and Textiles. The Company continued to deliver enhancements, based on its patented technology, to products in other areas where Directa Plus has identified significant potential commercial opportunities, including paints, filtration, Lithium-Sulphur batteries and composites.

 

Highlights

 

Financial & Operational

·

Revenue increased by +39% to €5.51m (1H2021: €3.95m)

·

Total income increased by +23% to €5.61m (1H2021: €4.56m)

·

Adjusted EBITDA loss* increased by 37% to €1.29m (1H2021: €0.94m), impacted by cost inflation as previously announced but with gross margin recovery expected by the end of H2

·

Adjusted loss before tax** increased by 14% to €1.99m (1H2021: €1.75m)

·

Cash at period end €7.78m (FY2021: €11.13m), in-line with management expectations

·

Approximately 10.4k cubic meters of sludge treated and 2.7k metric tonnes of hydrocarbons recovered

·

45k metres of textile printed, dyed and laminated in H1 2022

 

 

* Adjusted EBITDA loss represents results from operating activities before tax, interest, depreciation and amortisation, adjusted by one-off income, non-recurring legal expenses and non-recurring layoffs.

** Adjusted loss before tax represents Loss before tax adjusted by one-off income, non-recurring legal expenses, non-recurring layoffs and exchange rate gains/losses.

 

Target markets progress

Environmental remediation (76% of period revenue (1H2021: 75%))

·

In April 2022, Directa Plus received authorisation from the United States Environment Protection Agency for the Company's Grafysorber® technology to be used on any oil contamination in the US

·

Also in April 2022, the Company signed a first order of Grafysorber® based absorbing products from the UK's REDA Energy, a leading oil field chemical supplier, to initially target northern European markets

·

Post period end, in July 2022, the Company signed a Commercial Agreement with REDA Energy, to distribute Grafysorber® oil response products in specified European territories

 

 

Textiles (22% of period revenue (1H2021: 24%))

·

In April 2022, the Company signed a non-binding Letter of Intent with a leading international supplier of automotive interiors to Tier 1 manufacturers to develop a suite of new products

·

Post period end, in July 2022, the Company signed a supply agreement with Officine di Cartigliano, an Italian based leader in the production of tanning equipment, to use G+® pristine graphene nanoplatelets technology

·

In August 2022, the Company signed an extension to the exclusive supply agreement with Alfredo Grassi S.p.A., to broaden the existing collaboration to include G+® Thermal Planar Circuit® (PTC®) for the workwear market in Italy and France

·

In September 2022, the Company signed a commercial agreement with Schmid SpA, a leading fashion textile supplier, targeting the fashion footwear market and high-end bags, combining traditional fabrics with G+® textile technologies

 

 

Other verticals

·

In March 2022, Oxfordshire County Council began its second trial of GiPave®, a patented asphalt concrete modifier enhanced by the Company's G+® graphene.

·

In 1H22, the Company developed a graphene-based paints solution which provides enhanced anti-flame and anti-corrosion properties compared to normal paints, and is in discussion with potential partners

 

Innovation and IP

·

Directa Plus' current patent portfolio now comprises 80 granted patents plus 27 patents pending, grouped into 22 families, 4 covering G+ production and 18 covering G+® products and applications

·

In June 2022, the Company was granted an Italian patent covering the use of the Company's G+® pristine graphene nanoplatelets applied to textile substrates for high bacterial filtration efficiency media for filtration applications

·

In August 2022, the Company received the grant of the US patent titled "Golf ball comprising graphene"

·

In August 2022, the Company received a Notice of Allowance from the United States Patent and Trademark Office for the grant of a patent covering the Company's G+® embedded polyurethane membrane

 

Outlook

·

Significant continued revenue growth despite the uncertainty in the macro-economic climate

·

Cost increases seen during 1H22 have been addressed both through price increases for the Group's products and investment in new equipment that is expected to reduce direct production costs, with gross margin recovery expected in 2H22

·

The Company is still awaiting the final decision on the award of a significant contract in Romania for Environmental Remediation services but the Directors continue to believe that the Group is well positioned to win the tender

 

 

Giulio Cesareo, Founder & CEO of Directa Plus, said: "We maintain a positive outlook for the full year. However, this optimism must be tempered by the increasingly difficult macro-economic and geopolitical situation as inflation trends and supply chain issues could well worsen in the short term as we approach the northern hemisphere winter. Despite these pressures, the Directors believe that Directa Plus has positioned itself well to withstand headwinds and take full advantage of the technology platform we have developed which continues to gain further commercial traction."

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

Giorgio Bonfanti, CFO

Cenkos Securities plc (Nominated Adviser and Joint Broker)

+44 131 220 6939

Neil McDonald

Adam Rae

Singer Capital Markets (Joint Broker)

+44 20 7496 3069

Rick Thompson

Phil Davies

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson

Heather Armstrong

 

About Directa Plus

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.

 

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products. Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+®) have multiple applications due to its properties. These G+® products can be categorised into various families, with different products being suitable for specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. The Company holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.

 

Review of Operations

 

Environmental

The Group's subsidiary, Setcar, continues to grow and is delivering customer and revenue growth, making an important financial contribution to Directa Plus. Grafysorber®'s commercial traction, for water and soil decontamination, continues to increase with new customers won and repeat business from existing customers secured.

 

As announced during the capital raise in December 2021, the Group is investing in broadening its environmental remediation solutions. In 1H22 the Group installed a production facility for Grafysorber® materials for oil spill response products to increase production capacity and benefit from lower unit production costs. The Group is planning to move a second Grafysorber® mobile production unit into Romania to further increase its production capacity.

 

In Setcar's home market of Romania, the Group has established a successful growing business which supports plans to scale up and export to other markets. In April 2022, the Company received authorisation from the US Federal Environment Protection Agency (EPA) for Grafysorber® technology to be used on any oil contamination on US territory. Approval from the EPA is a vital first step towards entering the very large US oil decontamination market. The Group is seeking to enter Asian markets and is in talks with a number of important players in the oil industry as a first step with the goal in the medium term to access other verticals.

 

Just after the period end, in July 2022, the Company signed a Commercial Agreement with UK based REDA Energy Ltd to distribute Grafysorber® oil response products in agreed territories in Northern Europe. REDA Energy, a division of the REDA Group, is a leading chemical manufacturer and supplier of products and services to the global oil and gas sector. The Commercial Agreement follows the successful testing of Directa's products by REDA customers in the North Sea. These customers particularly appreciated the lightness and simplicity in handling, the effectiveness of absorption, and the reduced amount of plastic used in Grafysorber® booms and pillows. As a result of feedback from REDA Energy, Directa Plus has been able to further improve its oil spill response products, enhancing their ease of use and performance.

 

The first order from REDA for Grafysorber® products predates the Agreement and was delivered in June 2022 and comprised thousands of pillows and barriers. REDA will place a second similar order to build a minimum safety stock of products to cover northern Europe and will commence the distribution of Grafysorber® products to REDA customers. REDA is also considering wider opportunities for the application of the Group's water decontamination technology.

 

Textiles

The Textiles vertical continues to gain commercial traction and is expanding its broad spread of applications. Directa Plus has customers across a variety of markets who benefit from the advantages of G+® technology:

· Heat dispersion properties (Planar Thermal Circuit, PTC®)

· Antimicrobial (antiviral and antibacterial) properties

· Electrical conductivity properties

· No negative impacts on human skin

· Sustainable production process

 

Workwear

Post period end, in July 2022, the Company signed an extension to its exclusive supply agreement with Alfredo Grassi S.p.A. ("Grassi"), with whom Directa Plus has been working successfully for over five years, to broaden the existing collaboration to include Planar Thermal Circuit® (PTC®) for the workwear markets in Italy and France. This will enable the development of new products for Grassi that will increase comfort for the wearer - a key differentiator as climate change increases temperatures around the world.

 

Grassi is a leading European workwear and outerwear manufacturer, which has been operating since 1925. Grassi produces technical clothing for the industrial, sports and fashion industries, with a strong focus on innovation and sustainability. The supply agreement grants Grassi exclusive use of Directa Plus' proprietary PTC® G+® textile printing technology for the workwear market in France and Italy for a period of two years.

 

Both Directa Plus and Grassi see significant advantages from the deeper relationship, with Directa Plus gaining a recurring revenue stream for its G+® PTC® technology and Grassi benefitting from exclusive use of a sustainable textile technology with no biological impact. The agreement will also enable the Company to further develop its understanding of market trends and drivers affecting demand for workwear products.

 

Luxury

Directa Plus has been involved in the luxury market almost since inception and continues to see interest from brands in the development of innovative, technical new products to add to their collections. The Company continues to work with a major luxury Italian brand, which remains a customer since 2019 and relies on Directa Plus' technology to promote its technical fabrics collections.

 

Automotive

In April 2022, the Company signed a Letter of Intent (LOI) with a leading global supplier of automotive interiors to Tier 1 manufacturers. The supplier intends to develop a suite of new products for the automotive industry based on the antimicrobial properties (antibacterial and antiviral), thermal comfort and electrical conductivity properties of G+® enhanced fabrics.

 

The LOI has a 12-month term and sees Directa Plus and the supplier agree to combine resources, competence and expertise to develop G+® enhanced fabrics into a suite of ready to use products for the automotive industry. If both parties are satisfied with the results achieved after the 12 months, the partners shall undertake to negotiate a Supply Agreement between the two companies. Directa Plus is already working with the supplier to produce prototypes for a number of global Tier 1 auto manufacturers.

 

Air filters

In December 2021, the Company signed a Letter of Intent with an Italian based global chemicals and materials group which is a major player in the non-woven materials industry to collaborate on an exclusive basis for an initial period of 12 months. The collaboration sees Directa Plus' G+® technologies combined with those of the partner to develop specific products for the global air and water filtration markets. The technical development is yielding exciting results and the two companies are renewing the collaboration with the goal to accelerate the commercialisation of G+® functionalised non-woven materials.

 

Consumer electronics

Directa Plus continues to collaborate with the soft goods division of a major international developer and manufacturer of consumer electronics and related services. The agreement covers the potential application of G+® as a protective covering for consumer devices, exploiting its antiviral-antibacterial properties as well as its thermal and electrical conductivity. The partnership has delivered exceptional results to date. This collaboration continues to demonstrate the potential for significant volumes in the coming years.

 

Other textiles applications

Post period end, in July 2022, the Company signed a supply agreement with Officine di Cartigliano, for its G+® technology, worth €150,000 over one year on a take or pay basis. Officine di Cartigliano is the Italian based leader in the production of tanning equipment for the textile industry and will be using a formulation of the Company's G+® based textile finishing application to improve the performance of its equipment, particularly to address antistatic issues.

 

In June 2022, Directa Plus attended Techtextil in Germany, a leading international trade fair for technical textiles and nonwovens. International exhibitors presented the entire spectrum of technical textiles, functional apparel textiles and textile technologies. Directa Plus met with over 120 companies and more than 400 contacts at the fair, illustrating the traction that has been built for the Company's textile applications and the many potential future opportunities - mainly in the workwear and military segments.

 

Additional industrial verticals

 

Composites

The asphalt applications of Directa Plus's G+ graphene technology have great potential and the product developed with Iterchimica provides exceptional results in terms of increased durability and reduced carbon footprint. Despite a slower start than expected, interest in the market for the product is growing internationally and is gaining significant commercial traction.

 

In March 2022, Oxfordshire County Council started its second trial of a patented asphalt concrete modifier developed by Iterchimica and enhanced by the Company's Graphene Plus. The new trial will see two identical stretches of Marsh Lane in Oxford, which carries around 10,000 vehicles a day along a key city route, resurfaced with different materials. Half of a 700-metre stretch of the road will be laid with GiPave®, while the rest will be resurfaced using conventional asphalt, so that the two surfaces can be compared.

 

This second trial follows a successful first pilot scheme in Curbridge, Oxfordshire in 2019. Analysis of this scheme showed GiPave® increases the lifespan of the surface by up to 70 per cent compared to conventional resurfacing methods. The risk of rutting under loads from heavy goods vehicles is also reduced by increased stiffness in the product. 

 

GiPave® was developed by Iterchimica with the support of Directa Plus and resulted from a three-year research programme with a patent filed in 2017. The product uses waste plastics that would not normally be recycled and the asphalt containing GiPave® can itself be entirely recycled - promoting the 'circular economy,' which reduces waste and the need for new materials.

 

Lithium-Sulphur Batteries

Lithium-Sulphur is a next generation battery chemistry offering advantages over Lithium-Ion as it has a superior energy density, significant cost advantages and a superior safety profile. Directa Plus continues to support its partner NexTech in the development of this technology, in which G+® will play a key role in terms of technical properties and the supply of the product at the scale necessary to satisfy the needs of the market. In 1Q22 the parties agreed to remove the exclusivity clause originally agreed in the contract, and this will allow Directa Plus to collaborate with other players in the industry.

 

The Company remains focused on supporting the development of such a potentially disruptive technology and it has already targeted another Lithium-Sulphur battery producer to accelerate the technology's commercialisation.

 

Other areas

The Company continues to pursue additional opportunities in new growth verticals including paints, polymers, elastomers, golf balls, cements, and membranes.

 

The Company has developed a graphene-based paint solution which provides enhanced anti-flame and anti-corrosion properties compared to normal paints. Directa Plus has hired a team of experienced people in the field and has started discussions with international major players in Europe and Asia to accelerate commercialisation. The Group sees great potential in this developing technology.

 

Intellectual Property

 

As at September 2022, the Group's patent portfolio is comprised of 80 patents granted plus 27 patents pending. The patents are grouped into 22 families, four covering G+® production and 18 covering G+® products and applications.

 

In June 2022, the Company was granted an Italian patent covering the use of the Company's G+® applied to textile substrates for high bacterial filtration efficiency media for filtration applications. The priority date for the patent was 25 May 2020. G+® applied to textile substrates provides proven antibacterial and antiviral (including anti-SARS-CoV-2) performance. The target filtration market applications cover both medical and industrial use. Directa Plus started work on air filtration in 2020 with a signature project that successfully supplied face masks with anti-SARS-CoV-2 protection. This work led quickly into exploring industrial filtration applications starting with the automotive and HVAC (heating, ventilation and air conditioning) markets.

 

In August 2022, the Company received the grant of a US patent titled "Golf ball comprising graphene". The patent will enable Directa Plus to license its technology in the key US market. The patent priority date was 23 December 2016 and covers a variety of formulations containing G+® graphene nanoplatelets for application within golf balls. The use of G+® compounds in golf balls at different loadings has the potential for developing a whole new range of golf balls for professionals and amateurs. Different G+® graphene compounds within the golf ball will enable professionals to increase distance without losing lateral control or increase overall control of the ball for amateurs. The Company is now in discussions with potential partners to bring the technology to market.

 

In August 2022, the Company has received a Notice of Allowance from the United States Patent and Trademark Office for the grant of a patent covering the Company's G+® embedded polyurethane membrane, developed explicitly for the textile industry, together with its production method and its applications. The patent, titled "Polyurethane film comprising graphene and preparation process thereof", has a priority date of 5 May 2017. The official grant, expected shortly, will follow on from the completion of the filing process. G+® membranes are highly functional membranes that combine breathability and water protection with thermal and electrical conductivity. They provide superior thermal comfort by enhancing heat retention, due to high infrared absorption, while equalising it as a result of high in-plane thermal conductivity. They are electrically conductive, and the conductivity properties can be adjusted to confer antistatic behaviours for heating. Directa Plus' G+® membranes are non-toxic, non-cytotoxic, and safe against the skin. The membranes are used in apparel markets including the sportswear, workwear, military, luxury and accessories segments. In addition, they are being developed for use in the automotive, filtration and upholstery markets.

 

Financial

 

The Group's interim financials as of 30 June 2022 show a robust and continuous revenue growth of Directa Plus. During the first six months of the year, total revenues increased by 39% compared to the same period of 2021, reaching €5.51 million. The growth was driven by a strong performance by all the main verticals: Environmental Remediation +43% (€4.20 million), Textiles +26% (€1.19 million) and other verticals +86% (€0.12 million), the latter mainly thanks to the asphalts applications which are providing encouraging signals.

The first half of 2022 has been affected by a difficult and uncertain macro-economic environment caused by the consequences of the war in Ukraine. Input cost inflation, mainly driven by energy price increases, supply chain issues and recessionary destocking by suppliers meant that the Group had to deal with unexpected, and significant, cost increases which led to a reduction in profitability.

However, the Group is promptly reacting to mitigate the impact of such cost increases mainly through commercial actions: renegotiating principal contracts, and investing in new milling equipment that is expected to significantly reduce direct production costs, taking advantage from the throughput project started six years ago. As a result, gross margin recovery is continuing in the last quarter of 2022.

The table below shows a comparison of adjusted EBITDA loss and Loss before tax in the first half of 2022 and of the previous year. Adjustments refer to:

- €0.5 million of one-off other income reported in the 2021 accounts from the release of an undue obligation to the former shareholders of Setcar

- €0.05 million of legal expenses incurred in 1H22, mainly linked to the protection of Directa Plus' IP portfolio, following the potential breach of one of its patents in the textiles vertical

- €0.06 million of extraordinary severance pay

- Non-cash exchange rate effects (especially on the conversion GBP to EURO) which negatively affected this years profitability

 

As of 30 June 2022, Cash was €7.78m (€11.13m as of 31 December 2021). The Directors are satisfied that the Group has adequate resources to continue in operational existence for at least 12 months from approving these interim financial statements.

 

 

Board Composition

The Board is in advanced discussions to appoint a new non-executive director and has identified several other potential candidates. The Board remains committed to bring additional diversity and expertise to the Company.

 

Outlook

 

We have seen an increased level of interest in graphene and its applications as a whole, with Directa Plus receiving a materially higher level of enquiries from potential partners and customers. This has translated into continued growth despite the uncertainty in the macro-economic climate caused by the war in Ukraine, rising inflation driven mainly by energy cost increases and fears of recession. In 1H22, the Group experienced sudden and unexpected cost increases which led to a reduction in margin. The Group was impacted by higher energy and raw material costs, that directly affected its direct production costs, and general cost increases on outsourced services. These increases were addressed in two ways. Firstly, by price increases for the Group's products - major contracts with clients were renegotiated and secondly by an important cost reduction plan fostered by a new milling equipment that is expected to significantly reduce direct production costs. These measures will allow the Group to progressively recover margins over 2H22.

 

Directa Plus still awaits the final decision on the award of a significant contract in Romania for the Group's Environmental Remediation services but the Directors continue to believe that the Group is well positioned to win the tender.

 

In summary, the Board maintains a positive outlook for the full year. However, this optimism must be tempered by the increasingly difficult macro-economic and geopolitical situation as inflation trends and supply chain issues could well worsen in the short term as the northern hemisphere winter approaches. Despite these pressures, the Directors believe that Directa Plus has positioned itself well to withstand headwinds and take full advantage of the technology platform it has developed and that continues to gain further commercial traction.

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the six months ended 30 June 2022

In euro

Note

(Unaudited)

6 months ended

(Unaudited)

6 months ended

Audited

12 months ended

 

30 Jun 2022

30 Jun 2021

31 Dec 2021

Continuing operations

 

 

 

 

Revenue

5,508,706

3,950,559

8,615,098

Other income

100,667

613,651

831,405

Changes in inventories of finished goods and work in progress

174,084

293,498

12,960

Raw materials and consumables used

 

(2,984,979)

(1,300,320)

(3,634,311)

Employee benefits expenses

(2,259,310)

(1,996,322)

(4,296,955)

Depreciation and amortisation

(646,657)

(775,393)

(1,543,567)

Other expenses

 

(1,943,883)

(2,002,230)

(3,516,424)

Results from operating activities

(2,051,372)

(1,216,557)

(3,531,794)

 

Finance (expenses)/income

 

 

 

(160,504)

 

128,918

146,941

Net finance (costs)/income

(160,504)

128,918

146,941

 

Loss before tax

 

(2,211,876)

(1,087,639)

(3,384,853)

Tax expense

(6,149)

(116,640)

(44,620)

Loss after tax

(2,218,025)

(1,204,279)

(3,429,473)

Loss from continuing operations

(2,218,025)

(1,204,279)

(3,429,473)

Loss of the period

(2,218,025)

(1,204,279)

(3,429,473)

 

 

 

 

 

Other Comprehensive income items that will not be reclassified to profit or loss

 

 

 

 

Defined Benefit Plan remeasurement gains and losses

1,350

(6,917)

(6,457)

Other comprehensive income for the year (net of tax)

1,350

(6,917)

(6,457)

Total comprehensive income for the year

(2,216,675)

(1,211,196)

(3,435,930)

 

 

Loss attributable to

 

Owner of the Parent

(2,230,996)

(1,479,086)

(3,652,364)

Non-controlling interests

12,971

274,807

222,891

(2,218,025)

(1,204,279)

(3,429,473)

Total Comprehensive (loss)/ income attributable to

 

Owner of the Parent

(2,229,646)

(1,486,003)

(3,658,821)

Non-controlling interests

12,971

274,807

222,891

(2,216,675)

(1,211,196)

(3,435,930)

Loss per share

 

 

 

Basic loss per share

2

(0.03)

(0.02)

(0.06)

Diluted loss per share

2

(0.03)

(0.02)

(0.06)

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

As at 30 June 2022

 

In euro

Note

(Unaudited)

(Unaudited)

Audited

 

30 Jun 2022

30 Jun 2021

31 Dec 2021

Assets

 

Intangible assets

1,829,204

1,907,600

1,792,277

Property, plant and equipment

3,769,629

4,187,504

3,982,966

Trade and other receivables

553,904

135,036

185,623

Non-current assets

6,152,737

6,230,140

5,960,866

Inventories

 

1,597,476

1,657,947

1,370,875

Trade and other receivables

3,052,595

2,621,172

3,305,493

Cash and cash equivalent

7,776,689

5,191,533

11,130,468

Current assets

12,426,760

9,470,652

15,806,836

Total assets

 

18,579,497

15,700,792

21,767,702

 

Equity

 

Share capital

205,469

191,531

205,393

Share premium

39,181,789

31,395,612

39,159,027

Foreign currency translation reserve

(45,100)

(15,061)

(23,109)

Retained Earnings

(27,569,021)

(23,248,981)

(25,352,139)

Equity attributable to owners of Group

 

11,773,137

8,323,101

13,989,172

Non-controlling interest

1,880,198

2,101,286

2,041,938

Total equity

13,653,335

10,424,387

16,031,110

 

Liabilities

Loans and borrowings

1,687,953

1,890,196

2,403,881

Lease liabilities

363,877

462,192

463,047

Employee benefits

519,055

474,274

500,535

Other payables

64,392

64,636

64,357

Deferred tax liabilities

73,332

114,022

89,497

Non-current liabilities

2,708,609

3,005,320

3,521,317

Loans and borrowing

137,434

26,722

65,840

Lease liabilities

204,868

276,987

217,537

Trade payables and other payables

1,875,251

1,967,376

1,931,898

Current liabilities

2,217,553

2,271,085

2,215,275

Total liabilities

4,926,162

5,276,405

5,736,592

Total equity and liabilities

18,579,497

15,700,792

21,767,702

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

For the six months ended 30 June 2022

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

 

 

 

 

 

Share

Share

Foreign currency translation reserve

Retained Earnings

Total

Non-controlling

Total

In euro

Capital

premium

 

 

 

interests

Equity

Balance at 31 December 2020

190,996

31,395,612

(7,015)

(21,824,229)

9,755,364

906,885

10,662,249

Total comprehensive (loss)/income for the period

 

 

 

 

 

 

 

Loss of the Period

-

-

(1,479,086)

(1,479,086)

274,807

(1,204,279)

Total other comprehensive (expense)/income

-

-

(6,917)

(6,917)

-

(6,917)

Total comprehensive (loss)/income for the period

-

-

 

(1,486,003)

(1,486,003)

274,807

(1,211,196)

Capital raised

535

-

-

535

-

535

Translation reserve

-

-

(8,045)

(8,045)

-

(8,045)

Change of Setcar non-controlling interests

-

-

-

-

-

919,594

919,594

Share based payment reserve

-

-

-

61,251

61,251

-

61,251

Balance at 30 June 2021

191,531

31,395,612

(15,061)

(23,248,981)

8,323,101

2,101,286

10,424,387

Total comprehensive (loss)/income for the period

 

 

 

 

 

 

 

Loss of the Period

-

-

-

(2,173,278)

(2,173,278)

(51,916)

(2,225,194)

Total other comprehensive (loss)/income

-

-

-

461

461

-

461

Total comprehensive (loss)/income for the period

-

-

-

(2,172,817)

(2,172,817)

(51,916)

(2,224,733)

Capital raised

13,862

8,306,293

-

-

8,320,155

-

8,320,155

Expenditure related to the issuance of shares

(542,878)

-

(542,878)

-

(542,878)

Translation reserve

-

-

(8,048)

(8,048)

-

(8,048)

Change of Setcar non-controlling interests

-

-

-

-

-

(7,430)

(7,430)

Share based payment reserve

-

-

-

69,659

69,659

-

69,659

Balance at 31 December 2021

205,393

39,159,027

(23,109)

(25,352,139)

13,989,172

2,041,938

16,031,110

Total comprehensive (loss)/income for the period

 

 

 

 

 

 

 

Loss of the Period

-

-

-

(2,230,996)

(2,230,996)

12,971

(2,218,025)

Total other comprehensive (loss)/income

-

-

-

1,350

1,350

-

1,350

Total comprehensive (loss)/income for the period

-

-

-

(2,229,646)

(2,229,646)

12,971

(2,216,675)

Capital raised

77

22,762

-

-

22,838

-

22,838

Translation reserve

-

-

(21,991)

(21,991)

-

(21,991)

Change of Setcar non-controlling interests

-

-

-

-

-

(174,711)

(174,711)

Share based payment reserve

-

-

-

12,765

12,765

-

12,765

Balance at 30 June 2022

205,469

39,181,789

(45,100)

(27,569,021)

11,773,137

1,880,198

13,653,335

CONSOLIDATED STATEMENT OF CASH FLOW

For the six months ended 30 June 2022

(Unaudited)

(Unaudited)

Audited

30 Jun 2022

30 Jun 2021

31 Dec 2021

 

Loss for the year before tax

(2,211,876)

(1,087,639)

(3,384,853)

Adjusted for:

 

 

 

Depreciation

391,732

489,675

994,021

Amortisation of intangible assets

254,925

285,718

549,547

Share based payment expense

12,765

61,251

130,910

Finance income

(1,009)

(163,820)

(221,622)

Finance expense

153,812

13,970

56,524

Interest of lease liabilities

7,702

12,543

18,157

 

Operating cash flow before working capital changes

(1,391,949)

(388,302)

(1,857,316)

Decrease / (Increase) in inventories

(226,600)

(282,000)

5,072

Decrease / (Increase) in trade and other receivables, prepayments

(115,384)

241,900

(493,008)

(Decrease) / Increase in trade and other payables

(261,375)

(1,338,201)

(1,207,601)

Increase / (decrease) in provisions and employee benefits

11,360

16,765

37,457

Net cash used in operating activities

(1,983,948)

(1,749,838)

(3,515,396)

Cash flows from investing activities

 

 

 

Interest received

1,009

427

1,616

Investment in intangible assets

(291,853)

(120,445)

(299,056)

Contingent consideration

-

(442,205)

(572,268)

Acquisition of property, plant and equipment

(178,395)

(458,996)

(767,719)

Net cash used in investing activities

(469,239)

(1,021,219)

(1,637,427)

 

Cash flows from financing activities

 

 

 

Proceeds from Capital raise

22,838

535

8,320,690

Expenditure related to the issuance of shares

-

(542,878)

Interest Paid

(33,603)

(8,622)

(45,426)

New Borrowings

285,680

872,945

1,511,719

Repayment of borrowings

(930,013)

(35,214)

(81,666)

Repayment of lease liabilities

(111,840)

(102,894)

(179,646)

Net cash (used)/generated from financing activities

(766,938)

726,750

8,982,793

Net (decrease)/increase in cash and cash equivalent

(3,220,125)

(2,044,307)

3,829,970

Effect of exchange rate changes

(133,654)

155,348

220,006

Cash and cash equivalents at beginning of the period

11,130,468

7,080,492

7,080,492

Cash and cash equivalents at end of the period

7,776,689

5,191,533

11,130,468

 

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the 6 months ended 30 June 2022

 

1. Basis of preparation

(a) Statement of compliance

The financial information contained in this announcement does not constitute statutory financial statements within the meaning of Section 435 of the Companies Act 2006.

 

The financial information for the six months ended 30 June 2022 is unaudited. In the opinion of the Directors, the financial information for the period fairly represents the financial position of the Group. Results of operations and cash flows for the period are in accordance with international accounting standards in conformity with the requirements of the Companies Act 2006. The accounting policies, estimates and judgements applied are consistent with those disclosed in the Group's statutory financial statements for the year ended 31 December 2021. The interim condensed consolidated financial statements do not include all the information and disclosures required in the annual financial statements and should be read in conjunction with the full annual report for the year ended 31 December 2021.

 

All financial information is presented in Euro, unless otherwise disclosed.

 

The Directors of the Company approved the financial information included in these Interim condensed consolidated financial statements on 28 September 2022.

 

(b) Basis of measurement

The financial statements have been prepared on the historical cost basis unless otherwise stated.

 

 

(c) Functional and presentation currency

These financial statements are presented in Euro ('€') and is considered by the Directors to be the most appropriate presentation currency to assist the users of the financial statements. The functional currency of the Company and Italian operating subsidiary is Euro ('€'). The functional currency of the Romanian subsidiary is RON.

 

(d) Going concern

 

The Group meets its working capital requirements through the receipt of revenues from the provision of its services and sale of products mainly in Europe, the management of capital and operating expenditure, from the working capital and other borrowing facilities available to it and from the issue of equity capital.

As at 30 June 2022, the Group had net assets of €13.65m (31/12/2021: €16.03m) and cash and cash equivalent of €7.78m (31/12/2021: €11.13m).

The Directors prepare annual budgets and forecasts in order to ensure that they have sufficient liquidity in place in the business. The Group is projected to have the financial capacity to support its viability, following the uncertainties and challenges created by the COVID-19 pandemic and the inflation trends due to the war in Ukraine, until at least the end of 2023.

Having regard to the above and based on their latest assessment of the budgets and forecasts for the business of the company, the Directors consider that there are sufficient funds available to the Group to enable it to meet its liabilities as they fall due for a period of not less than twelve months from the date of approval of the financial statements. The Directors therefore consider it appropriate to adopt the going concern basis of accounting in preparing the financial statements.

 

2. Earnings Per Share

The earnings per share have been calculated using the weighted average of ordinary shares. The Company was loss making for all periods presented. Therefore, the dilutive effect of share options has not been taken account of in the calculation of diluted earnings per share, since this would decrease the loss per share for each of the period reported.

 

Change in

Total

 

Weighted

 

number of

number of

 

number of

 

ordinary

ordinary

 

ordinary

 

shares

shares

Days

shares

At 31 December 2019

12,530,156

60,998,983

365

52,973,511

At 31 December 2020

63,624

61,174,587

365

61,087,158

-At 31 December 2021

4,857,539

66,032,126

365

61,380,599

At 30 June 2022

25,523

66,057,649

181

66,049,470

 

Earnings per share

30 Jun 2022

30 Jun 2021

31 Dec 2021

Loss for the year

(2,230,996)

(1,479,086)

(3,652,364)

Weighted average number of shares:

- Basic

66,049,470

61,351,750

61,380,599

- Diluted

67,044,295

61,890,830

61,649,085

Loss per share

- Basic

(0.03)

(0.02)

(0.06)

- Diluted

(0.03)

(0.02)

(0.06)

 

 

 

 

 

-ends-

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BKFBBABKDDCB
Date   Source Headline
15th Apr 20243:01 pmRNSNotification of major holdings
12th Apr 20247:00 amRNSGiPave® installed at Imola Circuit
25th Mar 20247:00 amRNSEUR 1,000,000 Loan Agreement Signed
22nd Mar 20247:00 amRNSCollaboration with UK-based Heathcoat Fabrics
26th Feb 20247:00 amRNSAcquisition of 49% minority interest in Setcar
31st Jan 20247:00 amRNSContract win with FORD Otosan
20th Dec 20237:00 amRNSAcquisition of groundbreaking technology
15th Dec 202311:44 amRNSExpansion of collaboration with Miguel Caballero
10th Nov 20237:00 amRNSChange of Nominated Adviser
27th Sep 20237:00 amRNSHalf-year Report
18th Sep 20237:00 amRNSStrategic collaboration with The SPECTRUM Group
8th Sep 20237:00 amRNSNotice of Interim Results
7th Sep 20237:00 amRNSSignificant contract secured with LIBERTY Galati
19th Jul 20237:00 amRNSProject tender awarded
29th Jun 20237:00 amRNSDirecta Plus receives two new Italian patents
22nd Jun 20237:00 amRNSNew concept for produced water decontamination
15th Jun 20235:40 pmRNSResult of AGM
8th Jun 20237:00 amRNSNew product launch
19th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
10th May 20237:00 amRNSFinal Results
9th May 20237:00 amRNSNew contract with customer Alfredo Grassi
27th Apr 20237:00 amRNSNotice of Results Presentations
20th Mar 20237:00 amRNSNew Patent Granted
27th Feb 20237:00 amRNSTrading Update and Notice of Results
21st Dec 20227:00 amRNSNew significant contract with Pigmentsolution
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
2nd Dec 20227:00 amRNSTrading Update
29th Nov 20227:00 amRNSGrant Award
21st Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSFirst Commercial Contract in Latin America
21st Oct 20227:00 amRNSFirst Major Commercial Contract for Gipave
17th Oct 20227:00 amRNSBoar Changes
17th Oct 20227:00 amRNSBoard Changes
29th Sep 202211:05 amRNSSecond Price Monitoring Extn
29th Sep 202211:00 amRNSPrice Monitoring Extension
29th Sep 20227:00 amRNSHalf-year Report
1st Sep 20227:00 amRNSTrading Statement
30th Aug 20227:00 amRNSUS Patent Notice
4th Aug 20227:00 amRNSPartnership Extension and US Patent Award
19th Jul 20227:00 amRNSAgreement with REDA Energy for Grafysorber
5th Jul 20227:00 amRNSSupply Agreement
22nd Jun 20227:00 amRNSGrant of Italian Filtration Patent
17th Jun 20223:40 pmRNSResult of AGM
17th Jun 20227:00 amRNSAGM Statement
19th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
5th May 20227:00 amRNSFinal Results
22nd Apr 20227:00 amRNSPartnership to Develop Automotive Fabrics
4th Apr 20227:00 amRNSUS EPA Authorises Grafysorber for Use in US
7th Mar 20227:00 amRNSOxfordshire Starts Second Trial of GiPave

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.